mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
Gefitinib |
FIMM |
pan-cancer |
AAC |
-0.12 |
0.5 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.5 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.5 |